122 related articles for article (PubMed ID: 16707122)
1. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from the early non-obese diabetic mouse.
Gradin KA; Zhu H; Jeansson M; Simonsen U
Eur J Pharmacol; 2006 Jun; 539(3):184-91. PubMed ID: 16707122
[TBL] [Abstract][Full Text] [Related]
2. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
Gradin KA; Li JY; Andersson O; Simonsen U
J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
[TBL] [Abstract][Full Text] [Related]
3. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
[TBL] [Abstract][Full Text] [Related]
5. Blunted pancreatic polypeptide-induced vasodilatation in mesenteric resistance vessels from spontaneously hypertensive rats.
Gradin KA; Li JY; Zhu H; Simonsen U
Eur J Pharmacol; 2008 Dec; 601(1-3):118-23. PubMed ID: 18851959
[TBL] [Abstract][Full Text] [Related]
6. Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteries.
De Mey JG; Megens R; Fazzi GE
J Pharmacol Exp Ther; 2008 Mar; 324(3):930-7. PubMed ID: 18055875
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.
Gradin KA; Buus CL; Li JY; Frøbert O; Simonsen U
Br J Pharmacol; 2006 Jul; 148(5):703-13. PubMed ID: 16715120
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries.
Prieto D; Buus CL; Mulvany MJ; Nilsson H
Br J Pharmacol; 2000 Apr; 129(8):1689-99. PubMed ID: 10780975
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries.
Prieto D; Arcos LR; Martínez P; Benedito S; García-Sacristán A; Hernández M
Br J Pharmacol; 2004 Dec; 143(8):976-86. PubMed ID: 15557288
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses.
Gonzalez-Montelongo MDC; Fountain SJ
Vascul Pharmacol; 2021 Feb; 136():106810. PubMed ID: 33181321
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-independent potentiation by neuropeptide Y of vasoconstrictor responses in isolated arteries from rat and rabbit.
Gustafsson H; Nilsson H
Acta Physiol Scand; 1990 Apr; 138(4):503-7. PubMed ID: 2353579
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y induced attenuation of catecholamine synthesis in the rat mesenteric arterial bed.
Westfall TC; Naes L; Gardner A; Yang CL
J Cardiovasc Pharmacol; 2006 Jun; 47(6):723-8. PubMed ID: 16810071
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
[TBL] [Abstract][Full Text] [Related]
14. Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature.
Owen MP
J Pharmacol Exp Ther; 1993 May; 265(2):887-95. PubMed ID: 8496832
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse.
Mohammad MK; Morran M; Slotterbeck B; Leaman DW; Sun Y; Grafenstein Hv; Hong SC; McInerney MF
Int Immunol; 2006 Jul; 18(7):1101-13. PubMed ID: 16728431
[TBL] [Abstract][Full Text] [Related]
16. Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to alpha-adrenoceptor stimulation.
Mueed I; Zhang L; MacLeod KM
Br J Pharmacol; 2005 Dec; 146(7):972-82. PubMed ID: 16205724
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin facilitates reinnervation of phenol-injured perivascular nerves in the rat mesenteric resistance artery.
Hobara N; Goda M; Kitamura Y; Sendou T; Gomita Y; Kawasaki H
Neuroscience; 2007 Jan; 144(2):721-30. PubMed ID: 17101235
[TBL] [Abstract][Full Text] [Related]
18. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
Pernow J; Svenberg T; Lundberg JM
Eur J Pharmacol; 1987 Apr; 136(2):207-18. PubMed ID: 3595720
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in vascular reactivity to endothelin-1 (1-31) in mesenteric arteries from diabetic mice.
Matsumoto T; Kakami M; Kobayashi T; Kamata K
Peptides; 2008 Aug; 29(8):1338-46. PubMed ID: 18486991
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 2 receptors facilitate reinnervation of phenol-lesioned vascular calcitonin gene-related peptide-containing nerves in rat mesenteric arteries.
Hobara N; Goda M; Yoshida N; Takatori S; Kitamura Y; Mio M; Kawasaki H
Neuroscience; 2007 Dec; 150(3):730-41. PubMed ID: 17950540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
